IDF2022-0796 Sustained weight loss with ertugliflozin in patients with T2D and atherosclerotic cardiovascular disease in VERTIS CV

F. Cosentino,S. Dagogo-Jack, R. Frederich,C.P. Cannon,D.Z.I. Cherney, J.P. Mancuso, W. Wynant,J. Liu, N.B. Cater,R.E. Pratley

Diabetes Research and Clinical Practice(2023)

引用 0|浏览5
暂无评分
关键词
ertugliflozin,atherosclerotic cardiovascular disease,sustained weight loss
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要